Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1

Conditions

Advanced Malignant Neoplasm 1

Interventions

tipifarnib 1soybean oil, phospholipid emulsion 1penpulimab 1Sunscreening Agents 1Spironolactone 1Sorafenib 1Rifampin 1Morphine 1Methods 1Itraconazole 1Irinotecan 1Injections 1Infusions, Intravenous 1Hydrocortisone 1Genetic Testing 1Genetic Counseling 1Fat Emulsions, Intravenous 1Educational Status 1Early Intervention, Educational 1Doxycycline 1Docetaxel 1Counseling 1Cordotomy 1Acetates 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Advanced Malignant Neoplasm × Infusions, Intravenous × Other neoplasm × Clear all
NCT05048160 2022-05-09

A Clinical Study of 6MW3211 Injection in the Treatment of Advanced Malignant Neoplasm

Mabwell (Shanghai) Bioscience Co., Ltd.

Phase 1/2 Unknown
272 enrolled
Other neoplasm

Advanced Malignant Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡